BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 19136239)

  • 41. Managing the safety of inhaled corticosteroids in COPD and the risk of pneumonia.
    Liapikou A; Toumbis M; Torres A
    Expert Opin Drug Saf; 2015 Aug; 14(8):1237-47. PubMed ID: 26113207
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Use of long-acting beta-agonists and inhaled corticosteroids.
    Glassroth J
    Ann Intern Med; 2006 Nov; 145(9):710. PubMed ID: 17088595
    [No Abstract]   [Full Text] [Related]  

  • 43. Developments in inhaled combination therapies: patent activity 2013-2014.
    Norman P
    Expert Opin Ther Pat; 2015; 25(11):1239-45. PubMed ID: 26135360
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhaled beta-2 adrenergic receptor agonists and primary cardiac arrest.
    Lemaitre RN; Siscovick DS; Psaty BM; Pearce RM; Raghunathan TE; Whitsel EA; Weinmann SA; Anderson GD; Lin D
    Am J Med; 2002 Dec; 113(9):711-6. PubMed ID: 12517359
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacogenetics of β2-agonists.
    Hizawa N
    Allergol Int; 2011 Sep; 60(3):239-46. PubMed ID: 21681016
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pre-hospital use of inhaled corticosteroids and inhaled beta agonists and incidence of ARDS: A population-based study.
    Mangi AM; Bansal V; Li G; Pieper MS; Gajic O; Festic E
    Acta Med Acad; 2015; 44(2):109-16. PubMed ID: 26702906
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Investigating the steroids and long-acting beta 2-agonists combination: why do we need more?
    Papi A
    Eur Respir J; 2004 Apr; 23(4):501-2. PubMed ID: 15083743
    [No Abstract]   [Full Text] [Related]  

  • 48. Very high dose inhaled corticosteroids: panacea or poison?
    Russell G
    Arch Dis Child; 2006 Oct; 91(10):802-4. PubMed ID: 16990353
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Therapy of asthma using bronchodilator agents--special reference to adrenergic beta 2-receptor agonists].
    Kurosawa M; Igarashi Y; Miyachi Y
    Nihon Naika Gakkai Zasshi; 1996 Feb; 85(2):210-5. PubMed ID: 8708449
    [No Abstract]   [Full Text] [Related]  

  • 50. Combining inhaled glucocorticoids and long acting beta(2)-adrenoceptor agonists in asthma and COPD.
    Knox AJ; Mortimer K
    Br J Pharmacol; 2008 Mar; 153(6):1085-6. PubMed ID: 18223662
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Is the routine use of inhaled beta-adrenergic agonists appropriate in asthma treatment? No.
    Sears MR
    Am J Respir Crit Care Med; 1995 Mar; 151(3 Pt 1):600-1. PubMed ID: 7881644
    [No Abstract]   [Full Text] [Related]  

  • 52. Prevalence and associated factors of oropharyngeal side effects in users of inhaled corticosteroids in a real-life setting.
    Molimard M; Le Gros V; Robinson P; Bourdeix I
    J Aerosol Med Pulm Drug Deliv; 2010 Apr; 23(2):91-5. PubMed ID: 19778267
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long-term asthma therapy: adapt steroid therapy to severity.
    Prescrire Int; 2007 Oct; 16(91):208-11. PubMed ID: 17926841
    [TBL] [Abstract][Full Text] [Related]  

  • 54. New once-daily, long-acting inhaled β₂-agonist: what role will it play in the treatment of chronic obstructive pulmonary disease?
    McIvor RA
    Pol Arch Med Wewn; 2010 Oct; 120(10):381-2. PubMed ID: 20980942
    [No Abstract]   [Full Text] [Related]  

  • 55. [The effects of long-term inhaled glucocorticoids on children's bones].
    Nanulescu MV; Cherecheş-Panţa P; Crişan M; Farcău M; Popa M; Mureşan M; Boloşiu H; Siao-pin S
    Pneumologia; 2004; 53(1):53-9. PubMed ID: 18210724
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Management of COPD in community pharmacy].
    Mehuys E; Boussery K; Adriaens E; Van Bortel L; De Bolle L; Van Tongelen I; Remon JP; Brusselle G
    J Pharm Belg; 2010 Mar; (1):10-5. PubMed ID: 20429390
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The pharmacists' potential to provide targets for interventions to optimize pharmacotherapy in patients with asthma.
    van Boven JF; Hiddink EG; Stuurman-Bieze AG; Schuiling-Veninga CC; Postma MJ; Vegter S
    Int J Clin Pharm; 2013 Dec; 35(6):1075-82. PubMed ID: 23888347
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Is the routine use of inhaled beta-adrenergic agonists appropriate in asthma treatment? Yes.
    Wanner A
    Am J Respir Crit Care Med; 1995 Mar; 151(3 Pt 1):597-9. PubMed ID: 7881643
    [No Abstract]   [Full Text] [Related]  

  • 59. Interfaces to connect the HandiHaler and Aerolizer powder inhalers to a tracheostomy tube.
    Johnson DC
    Respir Care; 2007 Feb; 52(2):166-70. PubMed ID: 17261204
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bronchodilator treatment and deaths from asthma: case-control study.
    Anderson HR; Ayres JG; Sturdy PM; Bland JM; Butland BK; Peckitt C; Taylor JC; Victor CR
    BMJ; 2005 Jan; 330(7483):117. PubMed ID: 15618231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.